COVID-19 Resources 

Experimental Agent Reviews

Members from the Society of Infectious Diseases Pharmacists have prepared brief, evidence-based reviews of potential pharmacotherapeutic treatment options for COVID-19. These video presentations and handouts will be updated regularly as new data emerge on each of these experimental therapies. 

A Message from the SIDP President

Jason M. Pogue, PharmD, BCPS, BCIDP 


Below are links to 10-20 minute educational treatment presentations on each agent listed. 

Remdesivir (GS-5734) 

Speaker: Matt Davis, PharmD


Chloroquine & Hydroxychloroquine

Speaker: Zahra Kassamali Escobar, PharmD, BCIDP




Speaker: Julie Ann Justo, PharmD, MS, BCPS-AQ ID



Tocilizumab (Actemra®)

Speaker: Ana D. Vega, PharmD, BCIDP


Lopinavir/ritonavir (Kaletra®)

Speaker: Krutika Mediwala, PharmD, BCPS, BCIDP




To view all presentations on COVID-19, please click the link below. 

COVID-19 Videos

COVID-19 Literature

COVID-19 Treatment: A Review of Early and Emerging Options

A helpful review article published online on March 23, 2020 by Erin K. McCreary, PharmD, BCPS, BCIDP and Jason M. Pogue, PharmD, BCPS, BCIDP on behalf of SIDP

Society of Infectious Diseases Pharmacists • 121 W. State Street, Geneva, IL 60134
(630) 938-4732
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software